GR3035528T3 - Use of triazine compounds for the treatment of memory and learning disorders - Google Patents
Use of triazine compounds for the treatment of memory and learning disordersInfo
- Publication number
- GR3035528T3 GR3035528T3 GR20010400367T GR20010400367T GR3035528T3 GR 3035528 T3 GR3035528 T3 GR 3035528T3 GR 20010400367 T GR20010400367 T GR 20010400367T GR 20010400367 T GR20010400367 T GR 20010400367T GR 3035528 T3 GR3035528 T3 GR 3035528T3
- Authority
- GR
- Greece
- Prior art keywords
- memory
- treatment
- triazine compounds
- learning disorders
- disorders
- Prior art date
Links
- 208000020358 Learning disease Diseases 0.000 title 1
- 208000026139 Memory disease Diseases 0.000 title 1
- 201000003723 learning disability Diseases 0.000 title 1
- 150000003918 triazines Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939305693A GB9305693D0 (en) | 1993-03-19 | 1993-03-19 | Therapeutic triazine compounds and use |
| PCT/GB1994/000559 WO1994021260A1 (en) | 1993-03-19 | 1994-03-18 | Use of triazine compounds for the treatment of memory and learning disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3035528T3 true GR3035528T3 (en) | 2001-06-29 |
Family
ID=10732358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR20010400367T GR3035528T3 (en) | 1993-03-19 | 2001-03-08 | Use of triazine compounds for the treatment of memory and learning disorders |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0689439B1 (enEXAMPLES) |
| JP (1) | JPH08507782A (enEXAMPLES) |
| AP (1) | AP478A (enEXAMPLES) |
| AT (1) | ATE198831T1 (enEXAMPLES) |
| AU (1) | AU6217694A (enEXAMPLES) |
| DE (1) | DE69426622T2 (enEXAMPLES) |
| DK (1) | DK0689439T3 (enEXAMPLES) |
| ES (1) | ES2153854T3 (enEXAMPLES) |
| GB (1) | GB9305693D0 (enEXAMPLES) |
| GR (1) | GR3035528T3 (enEXAMPLES) |
| IL (1) | IL109034A (enEXAMPLES) |
| PT (1) | PT689439E (enEXAMPLES) |
| TW (1) | TW256773B (enEXAMPLES) |
| WO (1) | WO1994021260A1 (enEXAMPLES) |
| ZA (1) | ZA941938B (enEXAMPLES) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9424766D0 (en) * | 1994-12-07 | 1995-02-08 | Wellcome Found | Pharmaceutical composition |
| DE19603984A1 (de) * | 1996-02-05 | 1997-08-07 | Bayer Ag | Granulate von Triazinen |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA803250B (en) * | 1979-06-01 | 1982-01-27 | Wellcome Found | Substituded aromatic compounds |
| GB8613183D0 (en) * | 1986-05-30 | 1986-07-02 | Wellcome Found | Triazine salt |
| JP2632754B2 (ja) * | 1991-05-21 | 1997-07-23 | 塩野義製薬株式会社 | 脳内グルタミン酸遊離抑制剤 |
-
1993
- 1993-03-19 GB GB939305693A patent/GB9305693D0/en active Pending
-
1994
- 1994-03-18 JP JP6520807A patent/JPH08507782A/ja not_active Ceased
- 1994-03-18 DE DE69426622T patent/DE69426622T2/de not_active Expired - Fee Related
- 1994-03-18 AP APAP/P/1994/000627A patent/AP478A/en active
- 1994-03-18 IL IL10903494A patent/IL109034A/en active IP Right Grant
- 1994-03-18 AT AT94909263T patent/ATE198831T1/de not_active IP Right Cessation
- 1994-03-18 ZA ZA941938A patent/ZA941938B/xx unknown
- 1994-03-18 WO PCT/GB1994/000559 patent/WO1994021260A1/en active IP Right Grant
- 1994-03-18 TW TW083102373A patent/TW256773B/zh active
- 1994-03-18 AU AU62176/94A patent/AU6217694A/en not_active Abandoned
- 1994-03-18 PT PT94909263T patent/PT689439E/pt unknown
- 1994-03-18 ES ES94909263T patent/ES2153854T3/es not_active Expired - Lifetime
- 1994-03-18 DK DK94909263T patent/DK0689439T3/da active
- 1994-03-18 EP EP94909263A patent/EP0689439B1/en not_active Expired - Lifetime
-
2001
- 2001-03-08 GR GR20010400367T patent/GR3035528T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0689439B1 (en) | 2001-01-24 |
| AU6217694A (en) | 1994-10-11 |
| TW256773B (enEXAMPLES) | 1995-09-11 |
| GB9305693D0 (en) | 1993-05-05 |
| PT689439E (pt) | 2001-05-31 |
| AP478A (en) | 1996-03-08 |
| DK0689439T3 (da) | 2001-04-17 |
| ES2153854T3 (es) | 2001-03-16 |
| AP9400627A0 (en) | 1994-04-30 |
| IL109034A0 (en) | 1994-06-24 |
| EP0689439A1 (en) | 1996-01-03 |
| IL109034A (en) | 1998-12-06 |
| ATE198831T1 (de) | 2001-02-15 |
| DE69426622T2 (de) | 2001-06-21 |
| DE69426622D1 (de) | 2001-03-01 |
| WO1994021260A1 (en) | 1994-09-29 |
| ZA941938B (en) | 1995-09-18 |
| JPH08507782A (ja) | 1996-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA945545B (en) | Psoriasis treatment | |
| HU9503451D0 (en) | The treatment of small animals | |
| AU3959193A (en) | Heterocyclic compounds and their use in the treatment of type II-diabetes | |
| AU6946594A (en) | Methods for the treatment and prevention of diarrhea | |
| ZA944772B (en) | Treatment of fluids | |
| GB9308802D0 (en) | Treatment | |
| GR3035528T3 (en) | Use of triazine compounds for the treatment of memory and learning disorders | |
| HU9600882D0 (en) | Use of penciclorin for the treatment of post-therapeutic neuralgia | |
| GB2275191B (en) | Use of antifungal compounds in the treatment of skin disorders | |
| GB9305692D0 (en) | Therapeutic triazine compounds and use | |
| ZA945190B (en) | Carboxymethylidenecycloheptimidazole derivatives method or manufacturing the same and therapeutic agents containing these compounds | |
| SI0689439T1 (en) | Use of triazine compounds in the preparation of a medicament for the treatment of memory and learning disorders | |
| GB2279347B (en) | Boiler treatment | |
| GB9424471D0 (en) | Treatment of emesis | |
| GB9408916D0 (en) | Treatment of sewage | |
| GB2306096B (en) | The treatment of small animals | |
| ZA945032B (en) | Pyrimidones and imidazolinones for treatment of shock | |
| ZA922812B (en) | Use of 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds for the treatment of aids | |
| GB9308654D0 (en) | Therapeutic triazine compounds and use | |
| GB9311351D0 (en) | The treatment of small animals | |
| EP0596937A4 (en) | PLASMALOPSYCHOSINE AND PLASMALOCEREBROSIDE AND METHOD FOR TREATING NEURONAL DISEASES WITH THESE SUBSTANCES. | |
| ZA949927B (en) | Heterocyclic compounds for the treatment of cns and cardiovascular disorders | |
| SI0737189T1 (en) | Heterocyclic compounds for the treatment of cns and cardiovascular disorders | |
| EG19885A (en) | Medicament for the treatment of hyperlipidaemia and/or atherosolerosis | |
| GB9321591D0 (en) | Novel compounds and treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ML | Lapse due to non-payment of fees |